ArticleCancer management and research2021

Dynamics of Early Serum Tumour Markers and Neutrophil-to-Lymphocyte Ratio Predict Response to PD-1/PD-L1 Inhibitors in Advanced Non-Small-Cell Lung Cancer.

Yin Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.